Hikma Pharmaceuticals PLC is a multinational pharmaceutical company that develops, manufactures, and markets a broad range of generic, branded, and specialty medicines, with a particular focus on sterile injectable products. Founded in 1978 in Amman, Jordan, and headquartered in London, it supplies hospitals and pharmacies across the United States, the Middle East and North Africa, and Europe. The company is listed on the London Stock Exchange.
Hikma operates through three main segments—Injectables, Generics, and Branded—supported by in-house formulation development, aseptic manufacturing, and quality and regulatory capabilities. Its portfolio spans sterile injectables and finished oral and inhalation dosage forms used in critical care and other therapeutic settings. The company maintains a global network of R&D and manufacturing sites to supply essential medicines and help address healthcare system needs, including mitigating drug shortages.
Also known as Hikma.
None yet. When a new project in the record names Hikma Pharmaceuticals as owner, partner or investor, it shows here.
Ricardo Pravda, with 25+ years in HR, joins from Hikma Pharmaceuticals to lead global HR strategy, focusing on culture, talent, and growth.
